TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $372,000 | +1100.0% | 4,941 | +323.4% | 0.01% | – |
| Q1 2022 | $31,000 | -90.0% | 1,167 | -82.0% | 0.00% | -100.0% |
| Q4 2021 | $309,000 | -4.6% | 6,484 | +33.1% | 0.01% | -37.5% |
| Q3 2021 | $324,000 | +105.1% | 4,870 | +139.7% | 0.01% | +100.0% |
| Q2 2021 | $158,000 | -50.5% | 2,032 | -39.7% | 0.00% | -20.0% |
| Q1 2021 | $319,000 | -2.4% | 3,368 | +25.6% | 0.01% | -50.0% |
| Q4 2020 | $327,000 | +240.6% | 2,682 | +144.7% | 0.01% | +900.0% |
| Q3 2020 | $96,000 | -71.1% | 1,096 | -78.7% | 0.00% | -92.9% |
| Q2 2020 | $332,000 | +848.6% | 5,137 | +807.6% | 0.01% | +366.7% |
| Q4 2019 | $35,000 | -39.7% | 566 | -63.4% | 0.00% | -25.0% |
| Q3 2019 | $58,000 | +132.0% | 1,548 | +155.4% | 0.00% | +100.0% |
| Q2 2019 | $25,000 | – | 606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |